Literature DB >> 10886461

Cytochrome P450 2E1: its clinical and toxicological role.

E Tanaka1, M Terada, S Misawa.   

Abstract

Cytochrome (CYP) P450 2E1 is clinically and toxicologically important and it is constitutively expressed in the liver and many other tissues. In contrast to many other CYP isoenzymes, indisputable evidence for a functionally important polymorphism of CYP2E1 in the human population is lacking. CYP2E1 metabolizes a wide variety of chemicals with different structures, in particular small and hydrophobic compounds, including potential cytotoxic and carcinogenic agents. In addition, chlorzoxazone and trimethadione metabolism are good CYP2E1 probes for liver disease in vivo and in vitro. In the future, methods for fully analysing the function of CYP2E1 using knockout mice will be established. This article reviews recent advances in our understanding of the role of human CYP2E1 in drug metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886461     DOI: 10.1046/j.1365-2710.2000.00282.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  43 in total

1.  Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang
Journal:  World J Hepatol       Date:  2010-03-27

2.  Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego.

Authors:  Michael Fairhead; Silva Giannini; Elizabeth M J Gillam; Gianfranco Gilardi
Journal:  J Biol Inorg Chem       Date:  2005-11-09       Impact factor: 3.358

Review 3.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

Review 4.  How important are gender differences in pharmacokinetics?

Authors:  Bernd Meibohm; Ingrid Beierle; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

Authors:  Nicolas Vuilleumier; Michel F Rossier; Alberto Chiappe; Florence Degoumois; Pierre Dayer; Bernadette Mermillod; Laurent Nicod; Jules Desmeules; Denis Hochstrasser
Journal:  Eur J Clin Pharmacol       Date:  2006-04-27       Impact factor: 2.953

6.  Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line.

Authors:  Jian Zhuge; Ye Luo; Ying-Nian Yu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  Moderate hypothermia prevents cardiac arrest-mediated suppression of drug metabolism and induction of interleukin-6 in rats.

Authors:  Michael A Tortorici; Ying Mu; Patrick M Kochanek; Wen Xie; Samuel M Poloyac
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

Review 8.  Alcohol and acetaldehyde in public health: from marvel to menace.

Authors:  Rui Guo; Jun Ren
Journal:  Int J Environ Res Public Health       Date:  2010-03-25       Impact factor: 3.390

9.  Multiple-approaches to the identification and quantification of cytochromes P450 in human liver tissue by mass spectrometry.

Authors:  Cathrin Seibert; Brian R Davidson; Barry J Fuller; Laurence H Patterson; William J Griffiths; Yuqin Wang
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

Review 10.  CYP2E1 and oxidative liver injury by alcohol.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2007-11-17       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.